NCT01267448View on ClinicalTrials.gov

Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 9, 2014

Primary Completion Date

July 25, 2015

Study Completion Date

July 25, 2015

Conditions
Diabetes Mellitus Type 2Hyperglycemia
Interventions
DRUG

Glipizide XL

The control group will receive Glipizide XL (10mg orally) for a total duration of 12 weeks.

DRUG

Saxagliptin + Metformin XR

The intervention group will receive Saxagliptin 5 mg daily for a total duration of 12 weeks.

DRUG

Metformin XR

The intervention group will receive Metformin XR 1000 mg daily and will be automatically titrated weekly in 2 weeks to Metformin XR 2000 daily for a total duration of 12 weeks.

Trial Locations (1)

60612

John Stroger Hospital of Cook County, Chicago

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Cook County Health

OTHER_GOV